Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fadi Haidar

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Revue Medicale Suisse|March 6, 2023
[Collaboration in nephrology between Geneva and Yaoundé: a convincing example]Patrick Saudan, James Tataw, Fadi Haidar, et al.
RMD Open|December 10, 2024
Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysisAlexis F Guedon, Asmaa Ouafdi, Nabil Belfeki, et al.
Swiss Medical Weekly|August 14, 2025
Metabolic risk after living kidney donation: an analysis of the Swiss Organ Living-Donor Health RegistryJoana Krättli, Deborah Buess, Matthias Diebold, et al.
Frontiers in Medicine|March 1, 2024
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella species</i>Jakob E Brune, Michael Dickenmann, Daniel Sidler, et al.
Diagnostic and Prognostic Research|March 6, 2023
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocolSimon Schwab, Daniel Sidler, Fadi Haidar, et al.
Frontiers in Public Health|January 23, 2025
Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation systemMassimiliano Bertacchi, Sylvie Ferrari-Lacraz, Jakob Nilsson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 19, 2025
Impact of the Duration of Trimethoprim-Sulfamethoxazole Prophylaxis on the Incidence of Infection After Kidney Transplantation: A Target Trial Emulation Study Within the Swiss Transplant Cohort Study (STCS)-The QUID-PRO-QUO Study (QUIDney Transplantation and Duration of PROphylaxis With QUO-Trimoxazole)Aline Munting, Frédérique Chammartin, Isabelle Binet, et al.
Open Forum Infectious Diseases|March 11, 2024
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?Katharina Kusejko, Dionysios Neofytos, Christian van Delden, et al.
Transplantation Direct|October 14, 2024
Early Complications in Kidney Donors and Course of Health-related Quality of Life 12 mo After Donation: An Analysis of the Swiss Organ Living-Donor Health RegistryCharlotte Brügger, Zoé Hunkeler, Matthias Diebold, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantationElodie Bailly, Simon Ville, Gilles Blancho, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Revue Medicale Suisse|March 6, 2023
[Collaboration in nephrology between Geneva and Yaoundé: a convincing example]Patrick Saudan, James Tataw, Fadi Haidar, et al.
RMD Open|December 10, 2024
Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysisAlexis F Guedon, Asmaa Ouafdi, Nabil Belfeki, et al.
Swiss Medical Weekly|August 14, 2025
Metabolic risk after living kidney donation: an analysis of the Swiss Organ Living-Donor Health RegistryJoana Krättli, Deborah Buess, Matthias Diebold, et al.
Frontiers in Medicine|March 1, 2024
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella species</i>Jakob E Brune, Michael Dickenmann, Daniel Sidler, et al.
Diagnostic and Prognostic Research|March 6, 2023
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocolSimon Schwab, Daniel Sidler, Fadi Haidar, et al.
Frontiers in Public Health|January 23, 2025
Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation systemMassimiliano Bertacchi, Sylvie Ferrari-Lacraz, Jakob Nilsson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 19, 2025
Impact of the Duration of Trimethoprim-Sulfamethoxazole Prophylaxis on the Incidence of Infection After Kidney Transplantation: A Target Trial Emulation Study Within the Swiss Transplant Cohort Study (STCS)-The QUID-PRO-QUO Study (QUIDney Transplantation and Duration of PROphylaxis With QUO-Trimoxazole)Aline Munting, Frédérique Chammartin, Isabelle Binet, et al.
Open Forum Infectious Diseases|March 11, 2024
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?Katharina Kusejko, Dionysios Neofytos, Christian van Delden, et al.
Transplantation Direct|October 14, 2024
Early Complications in Kidney Donors and Course of Health-related Quality of Life 12 mo After Donation: An Analysis of the Swiss Organ Living-Donor Health RegistryCharlotte Brügger, Zoé Hunkeler, Matthias Diebold, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantationElodie Bailly, Simon Ville, Gilles Blancho, et al.
Pageof 5